"Aclarion significantly improved its financial and Nasdaq compliance positioning throughout Q1 such that we are now very well ...

Cooled radiofrequency ablation of lumbar nerves exhibited long-lasting, significant pain relief in patients with chronic low back pain.

For acute low back pain, there is moderate-certainty evidence that nonsteroidal anti-inflammatory drugs are an effective treatment.

The following is a summary of “Understanding patients’ perceptions of uncomplicated low back pain: a theory-informed ...

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...

On September 23, 2024, the Company's stockholders approved an amendment to the Company's Certificate of Incorporation to ...

This multi-part series explores the impact of MSK conditions, and the lessons benefit advisers learned as they sought ...

Open-label placebo yielded very modest analgesia in chronic low back pain, with better short- vs long-term outcomes.

Pooled data analysis shows that pain relief is only marginally better than placebo. A pooled analysis of existing research, ...

You'll stand up straighter and sleep more soundly with the best mattress for back pain. If the first thing you utter as you ...

Have you ever woken up feeling more tired than when you went to bed? Or experienced back pain that lasts for days or even ...

Only 1 in 10 nonsurgical treatments for low back pain are more effective placebo, a review of 56 different treatments and ...